Table 4.
Curcumin Doses | Effect on Gut Microbiota | Molecular Mechanisms | Model | Ref. |
---|---|---|---|---|
Curcumin at a low dose (1 g/day) | Curcumin shifted the structure of gut microbiota | Curcumin enervated the Western diet-induced development of atherosclerosis and type 2 diabetes mellitus | Sprague Dawley rats |
[225] |
100 mg/kg/day | Lowers the increasing abundance of the genera Anaerotruncus and Helicobacter in the gut microbiota | Decreases the estrogen level, resulting in an increase in body weight | Wistar rats | [226] |
100 mg/kg/day | Curcumin affected the presence of Prevotellaceae, Bacteroidacea, and Rikenellaceae in gut microbiota | Curcumin possesses anticancer activity in vitro and in preclinical animal models via the activation of caspases 3, 8 and 9 in the colon cancer cell lines | Fecal sample | [227] |
8000 mg per day | Increase in Lactobacillus and decrease in Coriobacterales | Induction of apoptosis through the COX-2 and non-COX-2 pathways. It targets cancer stem cells (CSC) through direct or indirect influences on the CSC self-renewal pathways. | Colon cancer cell lines, SW480 and SW62 | [228] |
0.2% (w/w) nanoparticles of curcumin | Increase in butyrate-producing bacteria and the fecal butyrate level | Mucosal mRNA expression of inflammatory mediators and the activation of NF-κB in colonic epithelial cells were suppressed by curcumin nanoparticles | BALB/c mice | [229] |